(PTCT) PTC Therapeutics - Performance 45% in 12m
Compare PTCT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
5.38%
#37 in Group
Rel. Strength
88.25%
#938 in Universe
Total Return 12m
44.96%
#29 in Group
Total Return 5y
2.74%
#42 in Group
P/E -
(?) Percentile in Group
P/E Forward 17.8
71th Percentile in Group
PEG 0.81
79th Percentile in Group
FCF Yield -2.22%
70th Percentile in Group
12m Total Return: PTCT (45%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: PTCT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PTCT
Total Return (including Dividends) | PTCT | XBI | S&P 500 |
---|---|---|---|
1 Month | 6.27% | 5.55% | -0.45% |
3 Months | -0.98% | -9.75% | -6.29% |
12 Months | 44.96% | -5.39% | 13.04% |
5 Years | 2.74% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | PTCT | XBI | S&P 500 |
1 Month | 74.9% | 70% | 47.5% |
3 Months | -26.8% | -88.1% | -87.3% |
12 Months | 85.3% | -44.4% | 54.3% |
5 Years | -41.8% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #107 | 0.68% | 6.74% |
3 Month | #61 | 9.72% | 5.67% |
12 Month | #28 | 53.2% | 28.3% |
5 Years | #42 | 18.4% | -51.5% |
FAQs
Does PTCT PTC Therapeutics outperforms the market?
Yes,
over the last 12 months PTCT made 44.96%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months PTCT made -0.98%, while XBI made -9.75%.
Over the last 3 months PTCT made -0.98%, while XBI made -9.75%.
Performance Comparison PTCT vs Indeces and Sectors
PTCT vs. Indices PTCT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.21% | 6.72% | 23.9% | 31.9% |
US NASDAQ 100 | QQQ | -3.13% | 4.37% | 23.2% | 30.0% |
US Dow Jones Industrial 30 | DIA | -1.67% | 9.12% | 24.7% | 35.7% |
German DAX 40 | DAX | -1.85% | 6.49% | 5.85% | 20.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.44% | 9.48% | 27.6% | 40.0% |
Hongkong Hang Seng | HSI | -1.81% | 7.79% | 23.4% | 32.0% |
India NIFTY 50 | INDA | 0.31% | 1.39% | 24.1% | 42.1% |
Brasil Bovespa | EWZ | -0.58% | 3.44% | 18.2% | 51.7% |
PTCT vs. Sectors PTCT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.36% | 6.87% | 18.0% | 21.5% |
Consumer Discretionary | XLY | -2.24% | 6.86% | 22.8% | 30.3% |
Consumer Staples | XLP | -0.15% | 7.09% | 19.8% | 34.0% |
Energy | XLE | 2.05% | 20.3% | 29.1% | 54.3% |
Financial | XLF | -1.10% | 8.28% | 17.0% | 22.3% |
Health Care | XLV | 0.49% | 10.9% | 29.1% | 46.2% |
Industrial | XLI | -2.53% | 5.97% | 22.9% | 34.3% |
Materials | XLB | -0.40% | 9.49% | 31.8% | 49.4% |
Real Estate | XLRE | -2.10% | 7.37% | 23.8% | 26.6% |
Technology | XLK | -3.77% | 3.84% | 26.9% | 34.5% |
Utilities | XLU | -0.93% | 6.17% | 19.5% | 24.2% |
Aerospace & Defense | XAR | -3.24% | -0.71% | 10.1% | 17.5% |
Biotech | XBI | -2.05% | 0.72% | 39.3% | 50.4% |
Homebuilder | XHB | -0.94% | 8.35% | 38.9% | 51.1% |
Retail | XRT | -0.97% | 7.43% | 29.9% | 46.5% |